Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
US7811602B2 · kind B2 · utility
64Cited by
41References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2005 |
| Grant date | Oct 12, 2010 |
| Priority date | — |
| Expiry date | Oct 16, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1278
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes novel liposomes comprising dihydrosphingomyelin. The invention also includes compositions comprising these liposomes and a therapeutic agent, in addition to methods and kits for delivering a therapeutic agent or treating a disease, e.g., a cancer, using these compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.